![From QSR to QMSR: Meeting FDA’s New Requirements From QSR to QMSR: Meeting FDA’s New Requirements](https://www.fdanews.com/ext/resources/Book-Covers-NEW/From-QSR-to-QMSR-500.png?height=200&t=1714569011&width=200)
Home » FDA Flags Another Record Year for Generic Approvals
FDA Flags Another Record Year for Generic Approvals
![Grey Approved Stamp](https://www.fdanews.com/ext/resources/test/Drug-Images4/Grey_Approved_Stamp.gif?t=1576541258&width=430)
January 6, 2020
FDA Commissioner Stephen Hahn announced that the FDA has seen yet another record-breaking year of generic drug approvals.
The agency approved 1,171 generics in fiscal 2019, up by 20 percent from 971 in fiscal 2018. The FDA has seen a steady increase in generic approvals since fiscal 2014 when it approved 500 products.
Hahn also announced the agency’s 98th first generic approval this year, a copycat version of Bristol-Myers Squibb and Pfizer’s anticoagulant Eliquis (apixaban).
Upcoming Events
-
21Oct